Attached files

file filename
8-K - 8-K - CRANE CO /DE/d287152d8k.htm
EX-99.1 - EARNINGS PRESS RELEASE - CRANE CO /DE/d287152dex991.htm

Exhibit 99.2

CRANE CO.

Income Statement Data

(in thousands, except per share data)

 

     Three Months Ended
December 31,
    Twelve Months Ended
December 31,
 
     2011     2010     2011     2010  

Net Sales:

        

Aerospace & Electronics

   $ 171,973      $ 161,059      $ 677,663      $ 577,164   

Engineered Materials

     45,037        44,975        220,071        212,280   

Merchandising Systems

     86,204        76,143        373,907        298,040   

Fluid Handling

     297,475        261,719        1,154,135        1,019,937   

Controls

     30,929        30,110        120,091        110,404   
  

 

 

   

 

 

   

 

 

   

 

 

 

Total Net Sales

   $ 631,618      $ 574,006      $ 2,545,867      $ 2,217,825   
  

 

 

   

 

 

   

 

 

   

 

 

 

Operating Profit (Loss):

        

Aerospace & Electronics

   $ 38,785      $ 33,156      $ 145,624      $ 109,228   

Engineered Materials

     4,562        3,466        29,754        30,143   

Merchandising Systems

     7,705        (2,611     30,337        16,729   

Fluid Handling

     38,804        29,252        152,066        122,590   

Controls

     3,211        2,943        14,658        5,843   

Corporate

     (13,748     (12,507     (58,201     (49,371

Asbestos Provision

     (241,647     —          (241,647     —     

Environmental Provision

     (30,327     —          (30,327     —     
  

 

 

   

 

 

   

 

 

   

 

 

 

Total Operating Profit (Loss)

     (192,655     53,699        42,264        235,162   

Interest Income

     514        424        1,635        1,184   

Interest Expense

     (6,730     (6,720     (26,255     (26,841

Miscellaneous- Net

     (452     527        2,810     1,424   
  

 

 

   

 

 

   

 

 

   

 

 

 

Income (Loss) Before Income Taxes

     (199,323     47,930        20,454        210,929   

Provision (Benefit) for Income Taxes

     (74,518     8,690        (6,062     56,739   
  

 

 

   

 

 

   

 

 

   

 

 

 

Net income (loss) before allocations to noncontrolling interests

     (124,805     39,240        26,516        154,190   

Less: Noncontrolling interest in subsidiaries’ earnings (losses)

     324        (148     201        20   
  

 

 

   

 

 

   

 

 

   

 

 

 

Net income (loss) attributable to common shareholders

   $ (125,129   $ 39,388      $ 26,315      $ 154,170   
  

 

 

   

 

 

   

 

 

   

 

 

 

Share Data:

        

Earnings (Loss) per Diluted Share

   $ (2.16   $ 0.66      $ 0.44      $ 2.59   
  

 

 

   

 

 

   

 

 

   

 

 

 

Average Diluted Shares Outstanding

     57,903        59,317        59,204        59,562   

Average Basic Shares Outstanding

     57,903        58,275        58,120        58,601   

Supplemental Data:

        

Cost of Sales

   $ 425,765      $ 385,381      $ 1,683,093      $ 1,472,602   

Asbestos Provision

     241,647        —          241,647        —     

Environmental Provision

     30,327        —          30,327        —     

Selling, General & Administrative

     126,534        134,926        548,536        510,061   

Depreciation and Amortization **

     15,735        15,245        62,943        59,841   

Stock-Based Compensation Expense

     3,840        3,676        14,972        13,326   

 

* Primarily related to the sale of a building and the divestiture of a small product line in the three months ended March 31, 2011.
** Amount included within cost of sales and selling, general & administrative costs.


CRANE CO.

Condensed Balance Sheets

(in thousands)

 

     December 31,
2011
     December 31,
2010
 

ASSETS

     

Current Assets

     

Cash and Cash Equivalents

   $ 245,089       $ 272,941   

Accounts Receivable, net

     349,250         301,918   

Current Insurance Receivable - Asbestos

     16,345         33,000   

Inventories, net

     360,689         319,077   

Other Current Assets

     60,859         61,725   
  

 

 

    

 

 

 

Total Current Assets

     1,032,232         988,661   

Property, Plant and Equipment, net

     284,146         280,746   

Long-Term Insurance Receivable - Asbestos

     208,952         180,689   

Other Assets

     497,377         446,316   

Goodwill

     820,824         810,285   
  

 

 

    

 

 

 

Total Assets

   $ 2,843,531       $ 2,706,697   
  

 

 

    

 

 

 

LIABILITIES AND EQUITY

     

Current Liabilities

     

Notes Payable and Current Maturities of Long-Term Debt

   $ 1,112       $ 984   

Accounts Payable

     194,158         157,051   

Current Asbestos Liability

     100,943         100,000   

Accrued Liabilities

     226,717         229,462   

Income Taxes

     10,165         11,057   
  

 

 

    

 

 

 

Total Current Liabilities

     533,095         498,554   

Long-Term Debt

     398,914         398,736   

Long-Term Deferred Tax Liability

     41,668         48,852   

Long-Term Asbestos Liability

     792,701         619,666   

Other Liabilities

     255,097         147,859   

Total Equity

     822,056         993,030   
  

 

 

    

 

 

 

Total Liabilities and Equity

   $ 2,843,531       $ 2,706,697   
  

 

 

    

 

 

 


CRANE CO.

Condensed Statements of Cash Flows

(in thousands)

 

     Three Months Ended     Twelve Months Ended  
     December 31,     December 31,  
     2011     2010     2011     2010  

Operating Activities:

        

Net income (loss) attributable to common shareholders

   $ (125,129   $ 39,388      $ 26,315      $ 154,170   

Noncontrolling interest in subsidiaries’ earnings (losses)

     324        (148     201        20   
  

 

 

   

 

 

   

 

 

   

 

 

 

Net income (loss) before allocations to noncontrolling interests

     (124,805     39,240        26,516        154,190   

Asbestos provision, net

     241,647        —          241,647        —     

Environmental provision, net

     30,327        —          30,327        —     

Gain on divestiture

     —          —          (4,258     (1,015

Depreciation and amortization

     15,735        15,245        62,943        59,841   

Stock-based compensation expense

     3,840        3,676        14,972        13,326   

Defined benefit plans and postretirement expense

     1,959        5,485        7,362        14,712   

Deferred income taxes

     (66,574     540        (44,835     31,453   

Cash provided by (used for) operating working capital

     34,957        48,105        (41,955     (8,262

Defined benefit plans and postretirement contributions

     (31,059 )*      (3,220     (48,113 )*      (43,226 )** 

Environmental payments, net of reimbursements

     (799     (158     (9,534     (11,063

Other

     (366     (11,601     (5,983     (9,689
  

 

 

   

 

 

   

 

 

   

 

 

 

Subtotal

     104,862        97,312        229,089        200,267   

Asbestos related payments, net of insurance recoveries

     (20,044     (23,079     (79,277     (66,731
  

 

 

   

 

 

   

 

 

   

 

 

 

Total provided by operating activities

     84,818        74,233        149,812        133,536   
  

 

 

   

 

 

   

 

 

   

 

 

 

Investing Activities:

        

Capital expenditures

     (7,034     (7,444     (34,737     (21,033

Proceeds from disposition of capital assets

     73        190        4,793        375   

Payment for acquisition, net of cash acquired

     (996     (89,294     (36,590     (140,461

Proceeds from divestiture

     —          —          1,000        4,615   
  

 

 

   

 

 

   

 

 

   

 

 

 

Total used for investing activities

     (7,957     (96,548     (65,534     (156,504
  

 

 

   

 

 

   

 

 

   

 

 

 

Financing Activities:

        

Dividends paid

     (15,035     (13,360     (56,992     (50,371

Reacquisition of shares on open market

     (30,000     (19,999     (79,999     (49,988

Stock options exercised - net of shares reacquired

     3,295        6,024        23,232        22,375   

Excess tax benefit from stock-based compensation

     391        1,470        6,097        3,290   

Change in short-term debt

     333        (440     (1,003     (2,739
  

 

 

   

 

 

   

 

 

   

 

 

 

Total used for financing activities

     (41,016     (26,305     (108,665     (77,433
  

 

 

   

 

 

   

 

 

   

 

 

 

Effect of exchange rate on cash and cash equivalents

     (1,939     5,997        (3,465     628   
  

 

 

   

 

 

   

 

 

   

 

 

 

Increase (decrease) in cash and cash equivalents

     33,906        (42,623     (27,852     (99,773

Cash and cash equivalents at beginning of period

     211,183        315,564        272,941        372,714   
  

 

 

   

 

 

   

 

 

   

 

 

 

Cash and cash equivalents at end of period

   $ 245,089      $ 272,941      $ 245,089      $ 272,941   
  

 

 

   

 

 

   

 

 

   

 

 

 

 

* Includes a $30 million discretionary pension contribution.
** Includes a $25 million discretionary pension contribution.


CRANE CO.

Order Backlog

(in thousands)

 

     December 31,     September 30,     June 30,      March 31,      December 31,  
     2011     2011     2011      2011      2010  

Aerospace & Electronics

   $ 410,794      $ 409,284      $ 431,799       $ 454,559       $ 431,467   

Engineered Materials

     11,110        9,879        13,087         13,826         11,831   

Merchandising Systems

     15,212        20,929        26,898         25,008         30,170   

Fluid Handling

     313,715     328,757     323,045         305,255         271,825   

Controls

     27,120        32,145        30,323         24,015         22,354   
  

 

 

   

 

 

   

 

 

    

 

 

    

 

 

 

Total Backlog

   $ 777,951      $ 800,994      $ 825,152       $ 822,663       $ 767,647   
  

 

 

   

 

 

   

 

 

    

 

 

    

 

 

 

 

* Includes Order Backlog of $7.1 million at December 31, 2011 and $5.4 million at September 30, 2011 pertaining to the 2011 acquisition of WTA.


CRANE CO.

Non-GAAP Financial Measures

(in thousands)

 

     Three Months Ended
December 31,
    Twelve Months Ended
December 31,
    Percent Change
December 31, 2011
    Percent Change
December 31, 2011
 
     2011     2010     2011     2010     Three Months     Twelve Months  
INCOME ITEMS             

Net Sales

   $ 631,618      $ 574,006      $ 2,545,867      $ 2,217,825        10.0     14.8

Operating Profit (Loss)

     (192,655     53,699        42,264        235,162        -458.8     -82.0

Percentage of Sales

     -30.5     9.4     1.7     10.6    

Special Items impacting Operating Profit (Loss):

            

Asbestos Provision - Pre-Tax (a)

     241,647        —          241,647        —         

Environmental Provision - Pre-Tax (b)

     30,327        —          30,327        —         

Restructuring Charges - Pre-Tax (c)

     —          7,841        —          6,676       

Non-deductible Acquisition Transaction Costs (d)

     —          1,276        —          1,276       
  

 

 

   

 

 

   

 

 

   

 

 

     

Operating Profit before Special Items

   $ 79,319      $ 62,816      $ 314,238      $ 243,114        26.3     29.3
  

 

 

   

 

 

   

 

 

   

 

 

     

Percentage of Sales

     12.6     10.9     12.3     11.0    

Net Income (Loss) Attributable to Common Shareholders

   $ (125,129   $ 39,388      $ 26,315      $ 154,170       

Per Share

   $ (2.16   $ 0.66      $ 0.44      $ 2.59        -425.4     -82.8

Special Items impacting Net Income (Loss) Attributable to Common Shareholders:

            

Asbestos Provision - Net of Tax (a)

     157,071          157,071         

Per Share

   $ 2.71        $ 2.65         

Environmental Provision - Net of Tax (b)

     19,713          19,713         

Per Share

   $ 0.34        $ 0.33         

Restructuring Charges - Net of Tax (c)

       5,293          4,470       

Per Share

     $ 0.09        $ 0.08       

Non-deductible Acquisition Transaction Costs (d)

       1,276          1,276       

Per Share

     $ 0.02        $ 0.02       

Reversal of Tax Provision on Undistributed Foreign Earnings (e)

     ($ 5,625     ($ 5,625    

Per Share

     $ (0.09     $ (0.09    
  

 

 

   

 

 

   

 

 

   

 

 

     

Net Income Attributable To Common Shareholders Before Special Items

   $ 51,654      $ 40,332      $ 203,098      $ 154,291        28.1     31.6
  

 

 

   

 

 

   

 

 

   

 

 

     

Per Basic Share

   $ 0.89      $ 0.69      $ 3.49      $ 2.63       

Per Diluted Share

   $ 0.88      $ 0.68      $ 3.43      $ 2.59        29.2     32.4

In the three months ended December 31, 2011, Average Shares Outstanding excluding the effect of diluted stock options were used to compute the per share amounts since this period was in a loss position. Had Net Income Attributable To Common Shareholders been reported for this period, Average Shares Outstanding would have included the effect of diluted stock options when computing per share amounts (see chart below).

 

Average Basic Shares Outstanding

     57,903   

Effect of Diluted Stock Options

     915   
  

 

 

 

Average Shares Outstanding including the effect of Stock Options

     58,818   

When considering the effect of dilutive stock options on shares outstanding, Net Income Attributable To Common Shareholders Before Special Items is $0.88 per share for the three months ended December 31, 2011.

 

 

(a) During the three months ended December 31, 2011, the Company recorded an Asbestos Provision.
(b) During the three months ended December 31, 2011, the Company recorded a charge related to an increase in the Company’s expected liability at its Goodyear, AZ Superfund Site.
(c) Amounts represent restructuring charges in connection with the Restructuring Program.
(d) During the three months ended December 31, 2010, the Company recorded non-deductible transaction costs associated with the acquisition of Money Controls.
(e) During the three months ended December 31, 2010, the Company recorded a tax benefit caused by the reinvestment of non-U.S. earnings associated with the acquisition of Money Controls.


     Three Months Ended
December 31,
    Twelve Months Ended
December 31,
 
     2011     2010     2011     2010  
CASH FLOW ITEMS         

Cash Provided by Operating Activities before Asbestos - Related Payments

   $ 104,862   $ 97,312      $ 229,089   $ 200,267 ** 

Asbestos Related Payments, Net of Insurance Recoveries

     (20,044     (23,079     (79,277     (66,731
  

 

 

   

 

 

   

 

 

   

 

 

 

Cash Provided by Operating Activities

     84,818        74,233        149,812        133,536   

Less: Capital Expenditures

     (7,034     (7,444     (34,737     (21,033
  

 

 

   

 

 

   

 

 

   

 

 

 

Free Cash Flow

   $ 77,784      $ 66,789      $ 115,075      $ 112,503   
  

 

 

   

 

 

   

 

 

   

 

 

 

 

* Includes a $30 million discretionary pension contribution.
** Includes a $25 million discretionary pension contribution.

Certain non-GAAP measures have been provided to facilitate comparison with the prior year.

The Company reports its financial results in accordance with U.S. generally accepted accounting principles (GAAP). However, management believes that non-GAAP financial measures which exclude certain non-recurring items present additional useful comparisons between current results and results in prior operating periods, providing investors with a clearer view of the underlying trends of the business. Management also uses these non-GAAP financial measures in making financial, operating, planning and compensation decisions and in evaluating the Company’s performance.

In addition, Free Cash Flow provides supplemental information to assist management and investors in analyzing the Company’s ability to generate liquidity from its operating activities. The measure of Free Cash Flow does not take into consideration certain other non-discretionary cash requirements such as, for example, mandatory principal payments on the Company’s long-term debt. Non-GAAP financial measures, which may be inconsistent with similarly captioned measures presented by other companies, should be viewed in addition to, and not as a substitute for, the Company’s reported results prepared in accordance with GAAP.

Non-GAAP financial measures, which may be inconsistent with similarly captioned measures presented by other companies, should be viewed in the context of the definitions of the elements of such measures we provide and in addition to, and not as a substitute for, the Company’s reported results prepared in accordance with GAAP.